Name: UMIN ID:
Unique ID issued by UMIN | UMIN000020977 |
---|---|
Receipt number | R000024207 |
Scientific Title | preoperative gemcitabine based chemoradiation therapy for resectable and borderline resectable pancreatic cancer phase1 study |
Date of disclosure of the study information | 2016/04/01 |
Last modified on | 2021/08/15 22:17:46 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2016/02/10 21:43:19 | ||
2 | Update | 2017/08/12 11:08:17 | Last name of lead principal investigator Last name of lead principal investigator Division name Division name Division name Division name Division name Division name Name of primary person or sponsor Institute Organization Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Institutions |
|
3 | Update | 2017/08/12 11:12:04 | Recruitment status |
|
4 | Update | 2020/04/24 03:07:10 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email3 Organization Organization Address Address Tel |
|
5 | Update | 2020/04/24 03:12:54 | Recruitment status Date of IRB Last follow-up date |
|
6 | Update | 2020/05/02 23:53:29 | Number of participants that the trial has enrolled |
|
7 | Update | 2020/05/02 23:55:45 | Last follow-up date |
|
8 | Update | 2020/05/03 01:58:43 | Key secondary outcomes Key secondary outcomes |
|
9 | Update | 2021/02/12 14:05:43 | Last follow-up date Date of closure to data entry Date trial data considered complete |
|
10 | Update | 2021/08/15 22:17:46 | Date trial data considered complete |